Personal information

No personal information available

Activities

Collapse all

Works (3)

Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study

Leukemia
2025-01 | Journal article
DOI: 10.1038/s41375-024-02422-4
Contributors: Yu-Hung Wang; Chao-Hung Wei; Chien-Chin Lin; Carmelo Gurnari; Hussein Awada; Lina Benajiba; Rafael Daltro de Oliveira; Juliette Soret-Dulphy; Bruno Cassinat; Andrius Zucenka et al.
Source: check_circle
Crossref

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification

Leukemia
2024-02 | Journal article
DOI: 10.1038/s41375-023-02114-5
Contributors: Hélène Pasquer; Rafael Daltro de Oliveira; Loic Vasseur; Juliette Soret-Dulphy; Nabih Maslah; Lin-Pierre Zhao; Clémence Marcault; Marine Cazaux; Nicolas Gauthier; Emmanuelle Verger et al.
Source: check_circle
Crossref

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms

Blood
2021-11-25 | Journal article
DOI: 10.1182/blood.2020010402
Contributors: Clémence Marcault; Lin-Pierre Zhao; Nabih Maslah; Emmanuelle Verger; Rafael Daltro de Oliveira; Juliette Soret-Dulphy; Marine Cazaux; Nicolas Gauthier; Blandine Roux; Emmanuelle Clappier et al.
Source: check_circle
Crossref
How many people are using ORCID?